Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v16-FR | Version v6-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2024-01-18 | 2023-12-12 |
| Drug Identification Number | 00886858 | 00886858 |
| Brand name | EMLA CREAM | EMLA CREAM |
| Common or Proper name | lidocaine 2.5% and prilocaine 2.5% 5g Tube with 2 Tegaderm dressings | lidocaine 2.5% and prilocaine 2.5% 5g Tube with 2 Tegaderm dressings |
| Company Name | ASPEN PHARMACARE CANADA INC. | ASPEN PHARMACARE CANADA INC. |
| Ingredients | LIDOCAINE PRILOCAINE | LIDOCAINE PRILOCAINE |
| Strength(s) | 2.5% 2.5% | 2.5% 2.5% |
| Dosage form(s) | CREAM | CREAM |
| Route of administration | TOPICAL TOPICAL | TOPICAL TOPICAL |
| Packaging size | 1 Tube | 1 Tube |
| ATC code | D04AB | D04AB |
| ATC description | ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC. | ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC. |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-12-15 | 2023-12-15 |
| Actual start date | 2023-12-20 | |
| Estimated end date | 2024-01-15 | 2024-01-01 |
| Actual end date | 2024-01-08 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | VR44798CA1 / CAD2EM012B1 EMLA 25MG:25MG/G CRE TB 1X5G CA ASP | CAD2EM012B1 EMLA 25MG:25MG/G CRE TB 1X5G CA ASP |
| Health Canada comments |